Now we are Novonesis

To get the latest news visit Novonesis.com

mountain landscape hit by sun rays

Want to get in touch with media relations?

Visit Novonesis.com for the latest contact information.

Filters

Latest headlines

198 results
HMO news article
20.03.24 | 8 minute read

UC San Diego and Novonesis join forces to pioneer Human Milk Oligosaccharide research

Global leader in biosolutions partners with top-ranking university to create new research incubator.
Stability_chocolate_squares_stack
12.03.24 | 8 minute read

Food For Your Mood

Novonesis to Unveil Fit-for-Food Mood-Support Probiotic at Natural Product Expo West in Anaheim, California. 
farming field with trackers harvesting crops
12.03.24 | 8 minute read

FMC to Distribute Novonesis’ Biosolutions for Plant Health in Canada

Novonesis announces an expanded partnership with FMC.
Healthy couple smiling
11.03.24 | 8 minute read

Novonesis probiotic strain receives health claim in Canada

Health Canada authorizes functional claims that the new probiotic strain CLEPIUS™ “helps alleviate perceived stress and improve irritable bowel syndrome-related quality of life in adults”.
HMO news article illustration
07.03.24 | 8 minute read

New Chinese review step achieved for Novonesis’ HMOs

All five single HMOs of Novonesis’ (previously Chr. Hansen) clinically documented 5 mix solution passed the biosafety review by the Chinese Ministry of Agriculture and Rural Affairs (MARA). 
Novonesis HQ in Lyngby, Denmark
01.02.24 | 8 minute read

Legacy Novozymes delivers solid last full-year results

Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023. This marks the last financial reporting from legacy Novozymes, and the new company, Novonesis, is already a reality.
Novonesis office
29.01.24 | 6 minute read

The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner

Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis is a world-leading biosolutions partner for better business, healthier lives, and a healthier planet. The combined company brings together 10,000 people worldwide and an expertise that spans more than 30 different industries. Novonesis is already assisting companies around the world in meeting both business needs and the needs of the planet.
Novonesis
13.12.23 | 8 minute read

Novozymes and Chr. Hansen announce name of future combined company; Novonesis

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION WOULD BE UNLAWFUL. Novozymes and Chr. Hansen have announced that the name of the future combined company will be ‘Novonesis’. Novonesis means ‘A new beginning’ and derives from the Greek word ‘genesis’. The name reflects a new era of biosolutions where innovation in biological sciences and technology will offer solutions to solve some of the biggest challenges facing humanity.
Oil and fats
09.11.23 | 8 minute read

Novozymes launches Quara® LowP for renewable diesel feedstock pre-treatment

Novozymes, a global leader in biosolutions, marks a significant milestone in the renewable diesel and SAF (Sustainable Aviation Fuel) industry with the launch of Quara® LowP, an enzymatic solution designed to transform the feedstock pre-treatment process.
Woman in supermarket
30.10.23 | 8 minute read

Not just yogurt anymore

Launched today: New super-stable probiotic lets functional food manufacturers go beyond dairy.
Novozymes Headquarters in Bagsvaerd, Denmark
26.10.23 | 8 minute read

Novozymes accelerates growth in Q3 and is on track to deliver on full-year expectations

After the first nine months of the 2023 financial year, Novozymes sees increasing demand for sustainable biosolutions and delivers 5% organic sales growth. The full-year organic sales growth outlook is maintained at 4-6%.
EPA Safer Choice Partner 2023
03.10.23 | 8 minute read

Novozymes named EPA Safer Choice Partner of the Year for third year in a row

World leader in biological solutions was recognized for providing and advocating for ingredients that create safer detergents. 

Executives & spokespeople

Executive leadership team

Images & video

Images

Stock videos

Novozymes logo